Medicare Enrolled
Dr. Deepna Jaiswal, D.O.
Hematology & Oncology · Plano, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jaiswal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jaiswal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jaiswal
Dr. Deepna Jaiswal is a hematology & oncology specialist in Plano, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Jaiswal performed 3,017 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Jaiswal received a total of $50,326 from 55 pharmaceutical and/or device companies across 369 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jaiswal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 42% volume in TX
$50,326 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,017
Medicare services
Top 42% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,112 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 400 | $1 | $52 |
| COVID-19 test, self-administered An FDA-approved, authorized, or cleared test kit for nonprescription self-administered and self-collected use. This code represents the provision of one test count. |
330 | $12 | $30 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
147 | $8 | $32 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
142 | $10 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
136 | $88 | $276 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
101 | $123 | $350 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
97 | $12 | $70 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
94 | $98 | $412 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
71 | $22 | $100 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
59 | $22 | $93 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $61 | $175 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
53 | $1 | $10 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
48 | $47 | $160 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
39 | $91 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
37 | $10 | $60 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
27 | $8 | $10 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
25 | $36 | $120 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
16 | $40 | $190 |
| New patient office visit, complex (60-74 min) | 15 | $157 | $500 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $133 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.0% high complexity
58.3% medium
35.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$50,326
Total received (2018-2024)
Avg $7,189/year across 7 years
Top 12% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
369
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$710
2023
$610
2022
$359
2021
$1,212
2020
$43,981
2019
$1,219
2018
$2,235
Payments by company (2024)
Daiichi Sankyo Inc.
$221
PFIZER INC.
$69
Novartis Pharmaceuticals Corporation
$50
ABBVIE INC.
$44
Gilead Sciences, Inc.
$44
AstraZeneca Pharmaceuticals LP
$41
Aveo Pharmaceuticals, Inc.
$30
JAZZ PHARMACEUTICALS INC.
$29
GENZYME CORPORATION
$27
Incyte Corporation
$25
Celgene Corporation
$25
Astellas Pharma US Inc
$23
Spectrum Pharmaceuticals Inc.
$21
ARRAY BIOPHARMA INC
$21
Merck Sharp & Dohme LLC
$21
Stemline Therapeutics Inc.
$19
Top 3 companies account for 48.0% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$42,103
AstraZeneca Pharmaceuticals LP
$3,710
Novartis Pharmaceuticals Corporation
$388
Lilly USA, LLC
$362
Genentech USA, Inc.
$332
PFIZER INC.
$317
Takeda Pharmaceuticals U.S.A., Inc.
$305
Clovis Oncology, Inc.
$258
Amgen Inc.
$241
Astellas Pharma US Inc
$209
Puma Biotechnology, Inc.
$162
GENZYME CORPORATION
$157
PUMA BIOTECHNOLOGY, INC.
$136
TESARO, Inc.
$121
E.R. Squibb & Sons, L.L.C.
$117
Celgene Corporation
$99
Bayer HealthCare Pharmaceuticals Inc.
$90
EMD Serono, Inc.
$75
Gilead Sciences, Inc.
$71
JAZZ PHARMACEUTICALS INC.
$52
Taiho Oncology, Inc.
$52
Merck Sharp & Dohme Corporation
$48
Sirtex Medical Inc
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
ABBVIE INC.
$44
Seattle Genetics, Inc.
$44
Merck Sharp & Dohme LLC
$44
Incyte Corporation
$44
Spectrum Pharmaceuticals Inc.
$41
Pharmacyclics LLC, An AbbVie Company
$40
TerSera Therapeutics LLC
$38
GlaxoSmithKline, LLC.
$37
Abbott Laboratories
$37
Lexicon Pharmaceuticals, Inc.
$36
Kyowa Kirin, Inc.
$30
Kite Pharma, Inc.
$30
Aveo Pharmaceuticals, Inc.
$30
Octapharma USA, Inc.
$30
Verastem, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
Otsuka America Pharmaceutical, Inc.
$25
Eisai Inc.
$23
Sun Pharmaceutical Industries Inc.
$22
ARRAY BIOPHARMA INC
$21
Ipsen Biopharmaceuticals, Inc
$19
Stemline Therapeutics Inc.
$19
Secura Bio, Inc.
$18
Seagen Inc.
$15
Baxter Healthcare
$14
Exelixis Inc.
$14
PharmaEssentia USA Corporation
$12
Tactile Systems Technology Inc
$12
Janssen Biotech, Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$12
Janssen Pharmaceuticals, Inc
$11
Top 3 companies account for 91.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Alecensa · Aliqopa · Avastin · BESREMI · BOSULIF · Bavencio · CALQUENCE · COPIKTRA · CYRAMZA · Cabometyx · Confirm Rx · Copiktra · DAURISMO · ELAHERE · ELIQUIS · ELITEK · ENHERTU · ENTRESTO · EPKINLY · ERBITUX · Ellipse ICD · Enhertu · FARESTON · FLEXITOUCH · FOTIVDA · Folotyn · Fortify Assura · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LYNPARZA · Lenvima · Lonsurf · MEKINIST · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OCTAGAM · OPDIVO · Orserdu · PADCEV · PIQRAY · PROMACTA · Padcev · Perjeta · Pomalyst · Prolia · REBLOZYL · ROLVEDON · Rubraca · SAMSCA · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · Stivarga · TALZENNA · TECENTRIQ · TISSEEL · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · XALKORI · XARELTO · XTANDI · Xermelo · Xofigo · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
129
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jaiswal is a mixed practice specialist, with moderate Medicare volume, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jaiswal experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Jaiswal performed 1,112 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jaiswal receive payments from pharmaceutical companies?
Yes. Dr. Jaiswal received a total of $50,326 from 55 companies across 369 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jaiswal's costs compare to other hematology & oncology specialists in Plano?
Dr. Jaiswal's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jaiswal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Plano
Browse hematology & oncology specialists in Plano ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology